Morris County EMS Alliance

06/12/2026

For critical FIFA-related updates, transportation information, and real-time public safety alerts in the NY/NJ region, download the New Jersey State Police Public Safety App. Staying informed is an important part of ensuring a safe and enjoyable event experience.

06/03/2026

https://www.stargazette.com/story/opinion/2026/06/01/ems-needs-volunteers-professionals-opinion/90351063007/?fbclid=IwdGRjcASNLkdjbGNrBI0t9mV4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHpWEueIIlTTv4Tv4EFa0Dt-rVkTy2wfjA7WRir1FZXX7eyqNuslbU5rrENyh_aem_zKJtvkYJal-ZI3NUH6Eqyw

Successful emergency responses depend on both professionals and volunteers. Let's invest in volunteers.

05/25/2026

Remembering all those that gave their life for our freedom.
Freedom isn't free.

05/17/2026

🚨 ACTION NEEDED BEFORE MONDAY MORNING 🚨
Happy National EMS Week



This Monday, May 18 at 10:00 AM, the NJ Senate Law and Public Safety Committee takes up Senate Bill S1421. As written, this bill could write volunteer EMS agencies out of the future of emergency medical services in New Jersey. Emails need to reach the committee TODAY — before the hearing.

━━━━━━━━━━━━━━━━━━━━
👉 WHAT TO DO RIGHT NOW (5 minutes)
━━━━━━━━━━━━━━━━━━━━

Email the five committee members below and ask them to amend S1421 to protect volunteer agencies. CC the sponsors.

EMAIL:
• [email protected]
• [email protected]
• [email protected]
• [email protected]
• [email protected]

CC:
• [email protected]
• [email protected]
• [email protected]

Suggested subject line: Please amend S1421 to protect volunteer EMS

━━━━━━━━━━━━━━━━━━━━
👉 THE TWO CHANGES WE'RE ASKING FOR
━━━━━━━━━━━━━━━━━━━━

S1421 defines "basic life support ambulance service" as an entity *licensed by the NJ Department of Health*. We are asking the committee to adopt two narrow amendments so volunteers aren't shut out:

1. In the definition of "basic life support ambulance service," add the words: "or a Member in Good Standing of the New Jersey State First Aid Council dba EMS Council of New Jersey."

2. Add volunteers and volunteer agencies to the list of entities permitted to provide EMS services.

These are small, specific edits — easy for the committee to adopt before the bill moves.

━━━━━━━━━━━━━━━━━━━━
👉 WHY THIS MATTERS TO US
━━━━━━━━━━━━━━━━━━━━

S1421 makes basic life support an "essential service" that every municipality must provide. That goal is a good one — and we support strong EMS coverage. The problem is the fine print: by tying that service to Department of Health licensure, the bill puts unlicensed volunteer squads at risk of no longer "counting" toward a town's requirement.

If a town can't count its volunteer squad, it may have little reason to keep funding one. For squads like ours, municipal support is the building, the ambulances, the fuel, and the insurance. Lose that footing and a volunteer agency's survival is genuinely in question.

DOH licensure also brings staffing rules many volunteer squads can't always meet — for example, two EMTs on every rig before it can leave the building. For us that would mean drivers could no longer crew alongside a single EMT, no direct response on critical calls, and shift coverage cut to a fraction of what it is today.

We are not opposing better EMS coverage. We are asking that the volunteers who have answered the call in this county for decades be written *into* this bill — not out of it.

🗓️ Hearing: Monday, May 18, 10:00 AM — Committee Room 10, 3rd Floor, State House Annex, Trenton, NJ. Please send your email before then.

05/10/2026

Happy Mother's Day our emts and to our emt's moms.
We hope you have a great day!

04/19/2026

𝗖𝘆𝗰𝗹𝗼𝗿𝗽𝗵𝗶𝗻𝗲: 𝗧𝗵𝗲 𝗢𝗽𝗶𝗼𝗶𝗱 𝗬𝗼𝘂 𝗗𝗼𝗻’𝘁 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗠𝗲𝗲𝘁 🚑

You are not seeing this one often. Yet.
But you need to know it before it shows up in your truck at 2 a.m.

Let’s get straight to it.

𝗪𝗵𝗮𝘁 𝗶𝘀 𝗰𝘆𝗰𝗹𝗼𝗿𝗽𝗵𝗶𝗻𝗲?

Cyclorphine is a semi-synthetic opioid.
It comes from the morphinan family. Same backbone as drugs like Morphine and Buprenorphine.

But it behaves differently.

* Mixed agonist-antagonist
* High affinity for the μ-opioid receptor
* Partial agonist at μ, antagonist or weak agonist at κ
* Very tight receptor binding

That last point matters.

It sticks. And it does not let go easily.

𝗪𝗵𝘆 𝗶𝘁’𝘀 𝗱𝗮𝗻𝗴𝗲𝗿𝗼𝘂𝘀

This is not about raw potency alone.
It is about receptor behavior.

Here’s what you need to understand at the bedside.

* High receptor affinity means it displaces other opioids
* Slow dissociation means prolonged effect
* Partial agonism means unpredictable ceiling effects
* Mixed activity means atypical toxidrome at times

You may not see the classic pinpoint pupils plus apnea combo.

You might see:

* Hypoventilation without full apnea
* Altered mental status that waxes and wanes
* Limited response to standard naloxone dosing
* Co-use with other opioids making everything worse

Now layer in polysubstance use. That is the real-world version.

𝗣𝗮𝘁𝗵𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆 𝘁𝗵𝗮𝘁 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 𝘁𝗼 𝘆𝗼𝘂

You already know μ-receptor activation depresses respiratory drive.

Cyclorphine complicates that.

* It binds tightly to μ-receptors in the brainstem
* It reduces responsiveness to CO₂
* It blunts medullary respiratory centers
* It does this while resisting displacement

So when you push naloxone, you are competing for the same receptor.

Naloxone has high affinity.
Cyclorphine has high affinity too.

Now it becomes a dose and timing fight.

𝗖𝗮𝗻 𝘆𝗼𝘂 𝗿𝗲𝘃𝗲𝗿𝘀𝗲 𝗶𝘁 𝘄𝗶𝘁𝗵 Naloxone?

Yes.
But do not expect easy wins.

What the literature and pharmacology suggest:

* Higher doses may be required
* Repeated dosing is often needed
* Continuous infusion may be necessary
* Re-sedation is a real risk

You may see partial reversal only.

That is not failure. That is the drug.

Clinical reality:

* Start with standard dosing
* Escalate quickly if no response
* Do not wait for textbook improvement
* Support ventilation early

Bagging a patient is not a defeat. It is the treatment.

𝗙𝗶𝗲𝗹𝗱 𝗮𝗻𝗱 𝘁𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵

This is where you earn your pay.

You do not need perfect diagnosis.
You need control of oxygenation and ventilation.

What you should do:

* Assess airway early
* Watch respiratory rate and tidal volume, not just SpO₂
* Use capnography, trends matter more than single numbers
* Give naloxone, titrate to respiratory effort, not full wake-up
* Be ready to repeat doses
* Consider infusion if transport time is long

If the patient does not respond:

* Assist ventilations
* Place advanced airway if needed
* Do not delay airway control waiting for naloxone to work

𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗰𝗮𝗿𝗲 𝗰𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀

Once you are in the air or on a long ground transport:

* Expect re-narcotization
* Monitor ETCO₂ continuously
* Prepare for sedation after reversal, agitation is common
* Watch for withdrawal if high naloxone doses are used
* Coordinate with receiving facility early

If you are running an infusion:

* Typical starting point 0.04 to 0.16 mg/kg/hr equivalent titration strategy based on response
* Adjust based on respiratory effort, not mental status

𝗪𝗵𝗮𝘁 𝘁𝗵𝗲 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝘀𝗮𝘆𝘀

Here is the honest part.

* Direct human data on cyclorphine toxicity is limited
* Most data comes from pharmacologic studies and receptor binding research
* Clinical guidance is extrapolated from partial agonists like buprenorphine

Strength of evidence:

* Mechanistic data, strong
* Animal and receptor studies, moderate
* Human clinical outcome data, limited

So when you treat these patients, you are applying physiology, not following a protocol built on large trials.

That is common in transport medicine.

𝗥𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀

* Not all opioid overdoses behave the same
* High-affinity opioids need aggressive and repeated reversal
* Ventilation is your priority, always
* Naloxone is a tool, not a guarantee
* Expect incomplete or delayed response

You will not out-pharmacology this drug every time.
But you can out-manage the airway.

𝗥𝗲𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀

1. Lewis JW et al. Cyclorphine and related compounds, pharmacology of mixed agonist-antagonist opioids. Journal of Medicinal Chemistry.
2. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine. Clinical Pharmacokinetics.
3. Kim HK, Nelson LS. Reversal of opioid-induced ventilatory depression using naloxone. Journal of Medical Toxicology.
4. Boyer EW. Management of opioid analgesic overdose. New England Journal of Medicine.
5. Wermeling DP. Review of naloxone safety for opioid overdose. Expert Opinion on Drug Safety.

04/14/2026

Welcome!
We are at the starting point. For next few weeks you'll see different groups of first responders being acknowledged for their role.
Our telecommunicators are the first, they answer the phone, text message, carrier pigeon, smoke signal... You get it, they answer. They got you first on probably the worst day of your life. Where would we be without them? Sitting home eating bonbons and having time with our family. But no, they have to call us over the air or hit the 'tones' get us to respond. So thanks to them, without them and you, we would be bored.

04/09/2026

I'm not promoting this app, I've not used it, but who knows it might help.
https://www.facebook.com/share/r/17tQuHLerN/